SCHEMBL1993499

SCHEMBL1993499

CCN1CCC(Cn2cc(C3=C(c4c[nH]c5ccsc45)C(=O)NC3=O)c3ccccc32)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKACA P17612 13/20 0.57
PRKACG P22612 13/20 0.57
PRKACB P22694 13/20 0.57
CAMK2D Q13557 8/20 0.49
PRKCB P05771 7/20 0.49
PRKCA P17252 7/20 0.49
PRKCG P05129 6/20 0.49
PRKCE Q02156 6/20 0.49
PRKCD Q05655 6/20 0.49
CAMK2B Q13554 4/20 0.49
CAMK2G Q13555 4/20 0.49
CAMK2A Q9UQM7 4/20 0.49
PRKCH P24723 4/20 0.49
PRKCZ Q05513 4/20 0.49
SRC P12931 3/20 0.49
SIRT2 Q8IXJ6 2/20 0.49
GSK3B P49841 4/20 0.46
CCNB2 O95067 2/20 0.46
CDK1 P06493 2/20 0.46
CCNB1 P14635 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1997192 0.91 PRKACA (0.56) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1990909 0.90 PRKACA (0.57) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1990789 0.89 PRKACA (0.53) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1991372 0.89 PRKACA (0.53) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1990585 0.89 PRKACA (0.56) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1992560 0.87 PRKACA (0.56) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1997364 0.84 CAMK2D (0.47) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1991464 0.84 PRKACA (0.55) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1991530 0.83 PRKACA (0.53) PRKACAPRKACGPRKACBCAMK2DPRKCB
SCHEMBL1993325 0.82 PRKACA (0.58) PRKACAPRKACGPRKACBCAMK2DPRKCB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO PRKACA 947/4885PRKACG 1317/4885PRKACB 1285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.